News Conference News EuroPCR 2024 Young, Low-risk Patients Fare Well With TAVI, but Beware the Bicuspids Michael O'Riordan May 15, 2024
Presentation EuroPCR 2024 First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2 Presenter: Ole De Backer May 15, 2024
News Conference News EuroPCR 2023 Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics Michael O'Riordan May 17, 2023
News Conference News EuroPCR 2022 CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial Yael L. Maxwell May 24, 2022